Concepedia

Caroline Morgan

CM

Statistics

Publications

12

Citations

1.1K

H-Index

11

Active since

2003

Affiliations

Cytel (United States)(Current)

Eli Lilly (United States)

Amgen (United States)

Roche (United Kingdom)

Cardinal Health (Australia)

Caroline Morgan is an author at Cytel (United States) specializing in experimental design, adaptive experimental designs, and clinical trials.

Publications per year

2003–2021

12

Publications

12

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

Christine Léauté-Labrèze, Peter H. Hoeger, J. Mazereeuw‐Hautier et al. · New England Journal of Medicine · 2015 · 781 citations · Full text

, , +8

Population pharmacokinetics of artesunate and amodiaquine in African children

Kasia Stepniewska, Walter Taylor, Sodiomon B. Sirima et al. · Malaria Journal · 2009 · 79 citations · Full text

, , +13

Adaptive Design: Results of 2012 Survey on Perception and Use

Caroline Morgan, Susan Huyck, Martin Jenkins et al. · Therapeutic Innovation & Regulatory Science · 2014 · 69 citations

, , +10

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum

Sodiomon B. Sirima, Alfred B. Tiono, Adama Gansané et al. · Malaria Journal · 2009 · 61 citations · Full text

, , +17

Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life

Laurence Guédon-Moreau, A. Capucci, Isabelle Denjoy et al. · EP Europace · 2010 · 42 citations · Full text

, , +7

1–5 of 12